Sebastien S Dufresne
Overview
Explore the profile of Sebastien S Dufresne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simard C, Roberge V, St-Pierre M, Cherblanc J, Bergeron-Leclerc C, Kadri M, et al.
Front Psychol
. 2024 Sep;
15:1419192.
PMID: 39295755
Background: Advances in pediatric oncology have significantly increased survival rates, yet have introduced challenges in managing long-term treatment side effects. This study process introduces an interdisciplinary clinical intervention program rooted...
2.
Peyrel P, Mauriege P, Frenette J, Laflamme N, Greffard K, Dufresne S, et al.
J Clin Lipidol
. 2024 Jan;
18(2):e269-e284.
PMID: 38177036
Background: Statins are the leading lipid-lowering drugs, reducing blood cholesterol by controlling its synthesis. Side effects are linked to the use of statins, in particular statin-associated muscle symptoms (SAMS). Some...
3.
Peyrel P, Mauriege P, Frenette J, Laflamme N, Greffard K, Dufresne S, et al.
PLoS One
. 2023 Jun;
18(6):e0281178.
PMID: 37315062
Background And Aims: Statin-associated muscle symptoms (SAMS) are frequently reported. Nevertheless, few data on objective measures of muscle function are available. Recent data suggesting an important nocebo effect with statin...
4.
Fontana Carvalho A, Dufresne S, de Oliveira M, Furlanetto K, Dubois M, Dallaire M, et al.
Eur J Phys Rehabil Med
. 2020 Feb;
56(3):297-306.
PMID: 32072792
Background: Low back pain is common during pregnancy. Lumbar stabilization and stretching exercises are recommended to treat low back pain in the general population. However, few studies have applied the...
5.
Rancourt A, Dufresne S, St-Pierre G, Levesque J, Nakamura H, Kikuchi Y, et al.
FASEB J
. 2018 Jun;
:fj201701151RRR.
PMID: 29894670
The muscle membrane, sarcolemma, must be firmly attached to the basal lamina. The failure of proper attachment results in muscle injury, which is the underlying cause of Duchenne muscular dystrophy...
6.
Dufresne S, Boulanger-Piette A, Bosse S, Argaw A, Hamoudi D, Marcadet L, et al.
Acta Neuropathol Commun
. 2018 Apr;
6(1):31.
PMID: 29699580
Although there is a strong association between osteoporosis and skeletal muscle atrophy/dysfunction, the functional relevance of a particular biological pathway that regulates synchronously bone and skeletal muscle physiopathology is still...
7.
Duchesne E, Dufresne S, Dumont N
Phys Ther
. 2017 Aug;
97(8):807-817.
PMID: 28789470
Anti-inflammatory modalities are commonly used for the treatment of various musculoskeletal injuries. Although inflammation was originally believed to interfere with skeletal muscle regeneration, several recent studies have highlighted the beneficial...
8.
Osteoprotegerin and β-Agonists Mitigate Muscular Dystrophy in Slow- and Fast-Twitch Skeletal Muscles
Dufresne S, Boulanger-Piette A, Frenette J
Am J Pathol
. 2017 Jan;
187(3):498-504.
PMID: 28041995
Our recent work showed that daily injections of osteoprotegerin (OPG)-immunoglobulin fragment complex (OPG-Fc) completely restore the function of fast-twitch extensor digitorum longus muscles in dystrophic mdx mice, a murine model...
9.
Boulanger Piette A, Dufresne S, Frenette J
BMC Musculoskelet Disord
. 2016 Oct;
17(1):449.
PMID: 27793139
Background: Cumulative evidence indicates that statins induce myotoxicity. However, the lack of understanding of how statins affect skeletal muscles at the structural, functional, and physiological levels hampers proper healthcare management....
10.
Dufresne S, Boulanger-Piette A, Bosse S, Frenette J
Receptors Clin Investig
. 2016 Aug;
3(2):e13231-e13236.
PMID: 27547781
The bone remodeling and homeostasis are mainly controlled by the receptor-activator of nuclear factor kB (RANK), its ligand RANKL, and the soluble decoy receptor osteoprotegerin (OPG) pathway. While there is...